In an unusual move, the chair of a Food and Drug Administration panel is defying a recommendation that his own panel made last week to endorse a powerful opioid painkiller, because he believes the drug represents a “danger” to public...
RT @ACCP: Join ACCP & @PCPCC in launching Better Health – Now on March 29, 1-2pm ET. We need strong #primarycare in every community so we a… —
1 year 1 week ago
